/Companies

Xenon Ophthalmics

Belleville, US · Founded 2019 · Delaware corporation

Find your way into Xenon Ophthalmics

Sign up to see every warm intro you have to Xenon Ophthalmics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Xenon Ophthalmics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

RG
Robert GilliganNamed on SEC filing
ZK
Zeshan KhanNamed on SEC filing
SS
Steve SusanibarNamed on SEC filing
BS
Bruce StarkNamed on SEC filing
MD
Michelle DeFossettNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 1 of 2 rounds · 2019–2023

▶$3.3MraisedOct 2026 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zeshan KhanExecutive Officer, Director
  • Steve SusanibarExecutive Officer
  • Robert GilliganDirector
  • Bruce StarkPromoter
  • David SingelynDirector
Amount sold
$3.3M
Minimum investment
$20K
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Xenon Ophthalmics raised?
Xenon Ophthalmics has disclosed $3.3M raised across 1 of its 2 known rounds.
Where is Xenon Ophthalmics headquartered?
Xenon Ophthalmics is headquartered in Belleville, US.